Status | Study |
Completed |
Study Name: Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Date: 2007-08-06 Interventions: Drug: saracatinib Given PO |
Completed |
Study Name: Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Date: 2007-07-26 Interventions: Drug: dasatinib Given PO or vi |
Completed |
Study Name: Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer Condition: Adenocarcinoma of the Colon Adenocarcinoma of the Rectum A Date: 2006-11-08 Interventions: Drug: cetuximab Given IV |
Completed |
Study Name: Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Date: 2006-10-12 Interventions: Drug: sunitinib malate Given orally Other Names: |
Completed |
Study Name: Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Date: 2005-01-07 Interventions: Drug: erlotinib hydrochloride |
Completed |
Study Name: Lapatinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Recurrent Date: 2004-12-07 Interventions: Drug: lapatinib ditosylate Giv |
Completed |
Study Name: S0420, Sorafenib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Date: 2004-11-09 Interventions: Drug: sorafenib tosylate Given |
Completed |
Study Name: SB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer Condition: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma Date: 2004-11-05 Interventions: Drug: ispinesib Given IV |
Completed |
Study Name: Alvespimycin Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors Condition: Male Breast Cancer Recurrent Adenoid Cystic Carcinoma of the Oral Cavity Date: 2004-08-04 Interventions: Drug: alvespimycin hydrochloride |
Completed |
Study Name: Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer Condition: Anaplastic Thyroid Cancer Insular Thyroid Cancer Metastati Date: 2003-09-10 Interventions: Drug: gefitinib Given orally Other Names: |